Dr. Ali Tinazli, PhD, is a transatlantic business leader and biophysicist with more than 15 years of C-suite and board-level experience driving commercial strategy across Health AI, MedTech, and advanced diagnostics. He serves as the Chief Executive Officer of lifespin GmbH, a digital health company specializing in the digitization of the human metabolome. Under his leadership, lifespin has built a large-scale reference dataset and AI analytics engine to enable real-time, blood-based diagnostics for early-stage disease detection and population-scale preventive care, recently launching a home self-collection kit and a General Health Assessment platform. A dual US-German citizen fluent in four languages, Dr. Tinazli’s career features high-impact roles at Fortune 100 giants, including serving as the Global Head of Healthcare and Life Sciences Strategy within the CTO Office at HP Inc. and establishing the Americas life sciences and in vitro diagnostics (IVD) business unit for Sony. Prior to lifespin, he was the Chief Commercial Officer for Fluxergy, where he launched point-of-care diagnostic tools into global markets. He holds a PhD in biochemistry and biophysics from Goethe University Frankfurt, completed executive corporate strategy programs at MIT Sloan and UC Berkeley Haas, and serves as a prominent corporate board advisor and international keynote speaker on precision medicine and multi-omics.